SBIR/STTR Research Award

Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide

Award identifier 5564c6e6cd2764eaaf50f3ac5baa7d6ede8c26ae134d3d5af0b32e0cc6a5c7ffAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,999,233

Program and phase

SBIR · Phase II

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Eclipse Bioinnovations, Inc.
Proposal award date
2021-09-22
Contract end date
2023-08-31
UEI
NKBUXMSL35L8
Solicitation number
PA20-260
Topic code
172

Research abstract

PROJECT SUMMARYPost-transcriptional regulation by microRNAs is fundamental for cellular homeostasis. MicroRNAs are small non-coding RNAs that fine tune gene expression by base pairing to complementary sequences in target messenger RNA (mRNA) molecules. A single microRNA can have multiple targets allowing for coordinated regulation of mRNA networks. The importance of microRNA regulation is evidenced not only by their evolutionary conservation but also by the involvement of microRNAs in nearly every biological process including proliferation, inflammation, development, and metabolism. Misregulation of individual microRNAs or global microRNA processing has important consequences for development, physiology, and disease. Aberrant microRNA expression has been linked to many diseases ranging from cancer to cardiac failure, and microRNAs have become attractive targets and tools for therapeutic approaches. Precise target identification of microRNAs is essential to understand their functional role. Current methods to identify microRNA targets are limited, as they have high false-positive rates, are unable to definitively distinguish direct from indirect microRNA-target interactions or are unable to profile low-abundance microRNAs. To this end we have applied our previously developed enhanced crosslinking and immunoprecipitation (eCLIP) technology to develop a specialized alternative, chimeric-eCLIP, to unambiguously identify microRNA targets in a transcriptome-wide manner. Chimeric-eCLIP is based on AGO2 eCLIP and includes a ligation step where microRNA and mRNA fragments are ligated to each other forming chimeric RNA molecules that can then be sequenced. Direct targets of individual microRNAs are easily identifiable from chimeric-eCLIP data using microRNA:mRNA chimeric reads. The work proposed here will expand the previously developed chimeric-eCLIP technology to include microRNA- and gene-specific read enrichment methods, and a user-friendly analysis package resulting in a robust and versatile chimeric-eCLIP kit for wide-spread use by academic and biotechnology industries, as outlined in the following aims:1. Expand direct profiling of microRNA targets with probe-based chimeric-eCLIP2. Refine software tools for analysis of chimeric-eCLIP data to strengthen key customer-facing features3. Conduct expanded beta testing and finalize commercialization of the all-inclusive chimeric-eCLIP kit Eclipse Bio is an ideal candidate to perform the aims described above due to our expertise in genomics, RNA processing, and computational biology. The above aims will enable robust microRNA target mapping to be performed using a standard method by all biomedical researchers and will allow for rigorous validation of microRNA specificity. The ability to properly assess therapeutic microRNA-like molecules will provide significant benefit to researchers studying microRNA regulation and companies developing RNA therapies.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2017–2025). Reported award amounts total $5,376,315. Reported amounts are not federal obligations.

Phases: Phase II, Phase I, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.